Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting minimal residual disease: a path to cure?
Marlise R. Luskin, Mark A. Murakami, Scott R. Manalis, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 4, pp. 255-263
Open Access | Times Cited: 135

Showing 26-50 of 135 citing articles:

Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein Biomarkers
Michael J. Duffy, John Crown
Clinical Chemistry (2022) Vol. 68, Iss. 11, pp. 1381-1390
Open Access | Times Cited: 35
Elucidating minimal residual disease of paediatric B-cell acute lymphoblastic leukaemia by single-cell analysis
Yingchi Zhang, Shicheng Wang, Jingliao Zhang, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 2, pp. 242-252
Closed Access | Times Cited: 31
Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications
Danielle Benedict Sacdalan, Sami Ul Haq, Benjamin H. Lok
Current Oncology (2024) Vol. 31, Iss. 1, pp. 482-500
Open Access | Times Cited: 7
Single-Cell Techniques and Deep Learning in Predicting Drug Response
Zhenyu Wu, Patrick J. Lawrence, Anjun Ma, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 12, pp. 1050-1065
Open Access | Times Cited: 44
Early Diagnosis and Screening for Lung Cancer
Humam Kadara, Linh M. Tran, Bin Liu, et al.
Cold Spring Harbor Perspectives in Medicine (2021) Vol. 11, Iss. 9, pp. a037994-a037994
Open Access | Times Cited: 40
Cancer immunotherapy
Ruby Dhar, Ashikh Seethy, Sunil Kumar Singh, et al.
Journal of Cancer Research and Therapeutics (2021) Vol. 17, Iss. 4, pp. 834-844
Open Access | Times Cited: 39
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
Mara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
JCI Insight (2021)
Open Access | Times Cited: 37
The methods and advances of adaptive immune receptors repertoire sequencing
Hongmei Liu, Wenjing Pan, Congli Tang, et al.
Theranostics (2021) Vol. 11, Iss. 18, pp. 8945-8963
Open Access | Times Cited: 36
Sublethal engagement of apoptotic pathways in residual cancer
Shane T. Killarney, Stephen W. G. Tait, Douglas R. Green, et al.
Trends in Cell Biology (2023) Vol. 34, Iss. 3, pp. 225-238
Closed Access | Times Cited: 16
Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer
Isaac García-Murillas, Rosalind J. Cutts, Giselle Walsh-Crestani, et al.
Breast Cancer Research and Treatment (2024) Vol. 209, Iss. 3, pp. 493-502
Open Access | Times Cited: 6
Long-term outcome of adjuvant radiotherapy upon postoperative relapse of centrally located hepatocellular carcinoma: a real-world study
Changcheng Tao, Nan Hu, Yue Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
YY2/BUB3 Axis promotes SAC Hyperactivation and Inhibits Colorectal Cancer Progression via Regulating Chromosomal Instability
Rendy Hosea, Wei Duan, Ian Timothy Sembiring Meliala, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Closed Access | Times Cited: 5
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
Rémy Gressin, Nicolas Daguindau, Adrian Tempescul, et al.
Haematologica (2018) Vol. 104, Iss. 1, pp. 138-146
Open Access | Times Cited: 46
Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer
Dadasaheb Akolkar, Darshana Patil, Timothy Crook, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 12, pp. 3485-3494
Open Access | Times Cited: 40
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells
Warren Fiskus, Christopher P. Mill, Behnam Nabet, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 5
Open Access | Times Cited: 29
Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas
Ying Cui, Hae-Suk Kim, Eunae Sandra Cho, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0256979-e0256979
Open Access | Times Cited: 29
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics
Bandari BharathwajChetty, Anjana Sajeev, Ravichandran Vishwa, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 321-362
Closed Access | Times Cited: 4
CRISPR-Cas9 in basic and translational aspects of cancer therapy
Maryam Samareh Salavatipour, Zahra Poursalehi, Negin Hosseini Rouzbahani, et al.
Bioimpacts (2024) Vol. 14, Iss. 6, pp. 30087-30087
Open Access | Times Cited: 4
Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)
Sakti Chakrabarti, Anup Kumar Kasi, Aparna R. Parikh, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3078-3078
Open Access | Times Cited: 18
Roadmap on plasticity and epigenetics in cancer
Jasmine Foo, David Basanta, Russell C. Rockne, et al.
Physical Biology (2022) Vol. 19, Iss. 3, pp. 031501-031501
Open Access | Times Cited: 17
Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases
Joel Baumgartner, Gregory P. Botta
Journal of Gastrointestinal Cancer (2023) Vol. 55, Iss. 1, pp. 41-46
Open Access | Times Cited: 11
Tumour excisional surgery, anaesthetic-analgesic techniques, and oncologic outcomes: a narrative review
O. C. Murphy, Patrice Forget, Daqing Ma, et al.
British Journal of Anaesthesia (2023) Vol. 131, Iss. 6, pp. 989-1001
Open Access | Times Cited: 10
3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline
Xingyun Yang, Mara Artibani, Yongcheng Jin, et al.
Advanced Healthcare Materials (2025)
Open Access
Circulating Tumor DNA as a Real-Time Biomarker for Minimal Residual Disease and Recurrence Prediction in Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis
Silvia Negro, Alessandra Pulvirenti, Chiara Trento, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2486-2486
Open Access
Advancing chronic myeloid leukemia research with next-generation sequencing: potential benefits, limitations, and future clinical integration
Henry Sutanto, Laras Pratiwi, Pradana Zaky Romadhon, et al.
Human Genetics (2025)
Closed Access

Scroll to top